184 related articles for article (PubMed ID: 26192379)
1. Infectious complications after liver transplantation in human immunodeficiency virus-infected recipients.
Teicher E; Boufassa F; Vittecoq D; Antonini TM; Tateo MG; Coilly A; Roque-Afonso AM; Kassis-Chikhani N; Lambotte O; Ichai P; Samuel D; Duclos-Vallee JC
Transpl Infect Dis; 2015 Oct; 17(5):662-70. PubMed ID: 26192379
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology and outcome of infections in human immunodeficiency virus/hepatitis C virus-coinfected liver transplant recipients: a FIPSE/GESIDA prospective cohort study.
Moreno A; Cervera C; Fortún J; Blanes M; Montejo E; Abradelo M; Len O; Rafecas A; Martín-Davila P; Torre-Cisneros J; Salcedo M; Cordero E; Lozano R; Pérez I; Rimola A; Miró JM;
Liver Transpl; 2012 Jan; 18(1):70-81. PubMed ID: 21898772
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of liver transplantation in HIV-infected individuals: the impact of HCV and HBV infection.
Norris S; Taylor C; Muiesan P; Portmann BC; Knisely AS; Bowles M; Rela M; Heaton N; O'Grady JG
Liver Transpl; 2004 Oct; 10(10):1271-8. PubMed ID: 15376307
[TBL] [Abstract][Full Text] [Related]
4. Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma.
Agüero F; Forner A; Manzardo C; Valdivieso A; Blanes M; Barcena R; Rafecas A; Castells L; Abradelo M; Torre-Cisneros J; Gonzalez-Dieguez L; Salcedo M; Serrano T; Jimenez-Perez M; Herrero JI; Gastaca M; Aguilera V; Fabregat J; Del Campo S; Bilbao I; Romero CJ; Moreno A; Rimola A; Miro JM;
Hepatology; 2016 Feb; 63(2):488-98. PubMed ID: 26516761
[TBL] [Abstract][Full Text] [Related]
5. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
[TBL] [Abstract][Full Text] [Related]
6. HCV recurrence in HIV-infected patients after liver transplant.
Hughes CB; Dickson RC; Krishna M; Willingham DL; Satyanarayana R; Harnois DM; Keaveny AP; Rosser B; Aranda-Michel J; Kramer DJ; Hellinger W; Mendez J
J Int Assoc Physicians AIDS Care (Chic); 2010; 9(2):87-93. PubMed ID: 20357036
[TBL] [Abstract][Full Text] [Related]
7. Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis.
d'Arminio Monforte A; Cozzi-Lepri A; Castagna A; Antinori A; De Luca A; Mussini C; Caputo SL; Arlotti M; Magnani G; Pellizzer G; Maggiolo F; Puoti M;
Clin Infect Dis; 2009 Aug; 49(4):612-22. PubMed ID: 19591597
[TBL] [Abstract][Full Text] [Related]
8. Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C.
Burak KW; Kremers WK; Batts KP; Wiesner RH; Rosen CB; Razonable RR; Paya CV; Charlton MR
Liver Transpl; 2002 Apr; 8(4):362-9. PubMed ID: 11965581
[TBL] [Abstract][Full Text] [Related]
9. Preservation of immune function and anti-hepatitis C virus (HCV) immune responses after liver transplantation in HIV-HCV coinfected patients (ANRS-HC08 "THEVIC" trial).
Samri A; Roque-Afonso AM; Beran O; Tateo M; Teicher E; Feray C; Sebagh M; Guettier C; Dussaix E; Vittecoq D; Samuel D; Autran B; Duclos-Vallée JC
J Hepatol; 2009 Dec; 51(6):1000-9. PubMed ID: 19833404
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus viral recurrence and liver mitochondrial damage after liver transplantation in HIV-HCV co-infected patients.
Duclos-Vallée JC; Vittecoq D; Teicher E; Feray C; Roque-Afonso AM; Lombès A; Jardel C; Gigou M; Dussaix E; Sebagh M; Guettier C; Azoulay D; Adam R; Ichaï P; Saliba F; Roche B; Castaing D; Bismuth H; Samuel D
J Hepatol; 2005 Mar; 42(3):341-9. PubMed ID: 15710216
[TBL] [Abstract][Full Text] [Related]
11. Human immunodeficiency virus-infected liver transplant recipients with incidental hepatocellular carcinoma: A prospective multicenter nationwide cohort study.
Agüero F; Forner A; Valdivieso A; Blanes M; Barcena R; Manzardo C; Rafecas A; Castells L; Abradelo M; Barrera-Baena P; González-Diéguez L; Salcedo M; Serrano T; Jiménez-Pérez M; Herrero JI; Gastaca M; Aguilera V; Fabregat J; Del Campo S; Bilbao I; Romero CJ; Moreno A; Rimola A; Miro JM;
Liver Transpl; 2017 May; 23(5):645-651. PubMed ID: 28188668
[TBL] [Abstract][Full Text] [Related]
12. Incidence and risk factors for herpes zoster in patients undergoing liver transplantation.
Hamaguchi Y; Mori A; Uemura T; Ogawa K; Fujimoto Y; Okajima H; Kaido T; Uemoto S
Transpl Infect Dis; 2015 Oct; 17(5):671-8. PubMed ID: 26201686
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes of orthotopic liver transplantation in human immunodeficiency virus-infected patients and comparison with human immunodeficiency virus-negative cases.
Baccarani U; Adani GL; Bragantini F; Londero A; Comuzzi C; Rossetto A; Lorenzin D; Bresadola V; Risaliti A; Pea F; Toniutto P; Donini A; De Anna D; Bresadola F; Tavio M; Viale P
Transplant Proc; 2011 May; 43(4):1119-22. PubMed ID: 21620067
[TBL] [Abstract][Full Text] [Related]
14. Liver transplantation in HIV-infected recipients.
Moreno S; Fortún J; Quereda C; Moreno A; Pérez-Elías MJ; Martín-Dávila P; de Vicente E; Bárcena R; Quijano Y; García M; Nuño J; Martínez A
Liver Transpl; 2005 Jan; 11(1):76-81. PubMed ID: 15690539
[TBL] [Abstract][Full Text] [Related]
15. [Descriptive study of infectious complications in 109 consecutive liver transplant recipients].
García-Prado E; Cordero E; Alamo JM; Gómez MA; Pascasio JM; Sánchez M; Cisneros JM
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):199-205. PubMed ID: 19361893
[TBL] [Abstract][Full Text] [Related]
16. Outcome after orthotopic liver transplantation in five HIV-infected patients with virus hepatitis-induced cirrhosis.
Radecke K; Frühauf NR; Miller M; Ross B; Köditz R; Malagó M; Broelsch CE; Gerken G; Treichel U
Liver Int; 2005 Feb; 25(1):101-8. PubMed ID: 15698406
[TBL] [Abstract][Full Text] [Related]
17. Impact of human immunodeficiency virus on survival after liver transplantation: analysis of United Network for Organ Sharing database.
Mindikoglu AL; Regev A; Magder LS
Transplantation; 2008 Feb; 85(3):359-68. PubMed ID: 18301332
[TBL] [Abstract][Full Text] [Related]
18. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
[TBL] [Abstract][Full Text] [Related]
19. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of hepatitis C infection after liver transplantation.
Gane EJ; Portmann BC; Naoumov NV; Smith HM; Underhill JA; Donaldson PT; Maertens G; Williams R
N Engl J Med; 1996 Mar; 334(13):815-20. PubMed ID: 8596547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
